Intravesical lignocaine in the diagnosis of bladder pain syndrome
- PMID: 19936591
- DOI: 10.1007/s00192-009-1045-0
Intravesical lignocaine in the diagnosis of bladder pain syndrome
Abstract
Introduction and hypothesis: To differentiate between the pain originating from urinary bladder and that due to other pelvic organs, using intravesical instillations of 2% lignocaine solution.
Methods: Twenty-two women with pelvic pain received intravesical instillation of 20 ml of 2% lignocaine solution. The intensity of pain was recorded by using visual analogue scale (VAS) just before, at 2, 10 and 20 min after intravesical instillation. Women who experienced a drop in the VAS score by 50% were termed as responders. All these women underwent cystoscopy under anaesthesia.
Results: Fifteen out of 22 (68.18%) women experienced a substantial reduction in the pain. Thirteen out of these 15 women had features suggestive of BPS/IC on cystoscopy. Out of the seven non-responders, two women were found to have endometriosis, four were diagnosed as pelvic inflammatory disease and one had diverticulitis.
Conclusions: Intravesical lignocaine appears to be useful in excluding patients with pelvic pain originating from organs other than the urinary bladder.
Similar articles
-
Beyond a Simple Anesthetic Effect: Lidocaine in the Diagnosis and Treatment of Interstitial Cystitis/bladder Pain Syndrome.Urology. 2015 May;85(5):1025-1033. doi: 10.1016/j.urology.2015.01.021. Urology. 2015. PMID: 25917728 Review.
-
Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution.J Sex Med. 2014 Sep;11(9):2256-63. doi: 10.1111/jsm.12507. Epub 2014 Mar 17. J Sex Med. 2014. PMID: 24636240
-
Intravesical hyaluronic acid and alkalinized lidocaine for the treatment of severe painful bladder syndrome/interstitial cystitis.Int Urogynecol J. 2012 Dec;23(12):1715-20. doi: 10.1007/s00192-012-1802-3. Epub 2012 May 11. Int Urogynecol J. 2012. PMID: 22576327 Clinical Trial.
-
Bladder instillation patterns in a cohort of women with interstitial cystitis/bladder pain syndrome.Urogynecology (Phila). 2023 Nov;29(11):914-919. doi: 10.1097/spv.0000000000001369. Urogynecology (Phila). 2023. PMID: 38107872 Free PMC article.
-
Advances in intravesical therapy for bladder pain syndrome (BPS)/interstitial cystitis (IC).Low Urin Tract Symptoms. 2018 Jan;10(1):3-11. doi: 10.1111/luts.12214. Low Urin Tract Symptoms. 2018. PMID: 29341502 Review.
Cited by
-
Validation study of new clinical scoring - "Apollo Clinical Scoring system" for bladder pain syndrome/interstitial cystitis and comparison of outcome with standard "O'Leary-Sant score".Int Urogynecol J. 2024 Jun;35(6):1137-1144. doi: 10.1007/s00192-023-05641-y. Epub 2023 Aug 29. Int Urogynecol J. 2024. PMID: 37642668
-
Prospective comparative study of the effects of lidocaine on urodynamic and sensory parameters in bladder pain syndrome.Int Urogynecol J. 2019 Aug;30(8):1293-1301. doi: 10.1007/s00192-019-03892-2. Epub 2019 Mar 14. Int Urogynecol J. 2019. PMID: 30874834 Free PMC article.
-
Evaluation of the female with chronic urologic pain.Can Urol Assoc J. 2018 Jun;12(6 Suppl 3):S149-S151. doi: 10.5489/cuaj.5321. Can Urol Assoc J. 2018. PMID: 29875038 Free PMC article. Review. No abstract available.
-
CUA guideline: Diagnosis and treatment of interstitial cystitis/bladder pain syndrome.Can Urol Assoc J. 2016 May-Jun;10(5-6):E136-E155. doi: 10.5489/cuaj.3786. Epub 2016 May 12. Can Urol Assoc J. 2016. PMID: 27790294 Free PMC article. No abstract available.
-
Interstitial cystitis/bladder pain syndrome: diagnosis and management.Int Urogynecol J. 2013 Aug;24(8):1243-56. doi: 10.1007/s00192-013-2057-3. Epub 2013 Feb 22. Int Urogynecol J. 2013. PMID: 23430074 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical